What happens when you stop metformin?

Reviewed 13 sourcesPublished by PepVault

Stopping metformin lets blood sugar drift back up: in the DPP, a 1 to 2 week break erased a quarter of its effect. Weight, B12, and the label's pause rules.

A blank white sheet, a coffee mug, oranges and mint on a wooden table, a hand in a grey sleeve
Last reviewed
Sources
13
Questions
7
Compounds
1

The short answer

Your blood sugar drifts back toward where it was before you started. About 90% of an absorbed dose leaves within a day, and in the Diabetes Prevention Program a 1 to 2 week break erased about a quarter of its benefit. Stomach side effects fade, low vitamin B12 tends to recover, and some weight can return. Stopping or pausing it is your prescriber's decision.

Every number checked at its primary source · · 13 sources · How we research

Evidence: The FDA label; one randomized, blinded washout inside the Diabetes Prevention Program and one randomized trial followed after stopping; the rest are observational cohorts and records studies, which show associations, not cause.

A blank white sheet, a coffee mug, oranges and mint on a wooden table, a hand in a grey sleeve

How fast does metformin leave your body?

Fast. About 90% of an absorbed dose leaves through the kidneys within 24 hours, and the label puts its half-life in plasma (the liquid part of blood) at about 6.2 hours1. A half-life is the time it takes for half of the drug to clear. In whole blood it is longer, about 17.6 hours, because some metformin sits in red blood cells, and both stretch out when the kidneys work less well1.

So metformin does not fade out slowly the way a weekly injection does. In the Diabetes Prevention Program, the part of its effect that came from the drug itself was gone after a 1 to 2 week break2, and what happens next depends on what it was doing for you. The label describes no withdrawal reaction and gives no taper schedule; its Patient Information says that after a missed dose you take the next one as prescribed, with no extra dose the next day1.

PepVault reminds you at your dose times and logs each tablet as taken, so a missed day shows as missed rather than guessed. Set reminders in PepVault

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault reminds you at your dose times and logs each tablet as taken, so a missed day shows as missed rather than guessed.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What happens to blood sugar when you stop metformin?

It climbs back toward where it was before metformin, unless something else takes its place. In the label's 29-week trial, metformin lowered fasting glucose by 53 mg/dL and HbA1c (the blood test of your average sugar over 2 to 3 months) by 1.4 points, while both rose a little on placebo1. That gap is what is at stake when the tablets stop.

StudyWho stoppedWhat happened
Diabetes Prevention Program washout21,274 adults with prediabetes, off the pills for 1 to 2 weeksBefore the break, the odds of diabetes on metformin were a third lower than on placebo (odds ratio 0.66). During the break, more new cases turned up in the metformin group (odds ratio 1.49, not statistically significant). Counting both, 25% fewer cases
US veterans4179 adults with type 2 diabetes, stopped over kidney numbersHbA1c 7.7% before, peak 8.3% within a year; back to 7.6% once other drugs were added
Hong Kong records57,500 adults who stopped after eGFR fell below 30HbA1c up 0.5 points at 6 months, against 0.2 in those who kept taking it
Singapore clinic769 adults, stopped for falling kidney functionNo change in HbA1c or weight at 6 months; most had other diabetes drugs raised

The washout is the cleanest test, because it was randomized and blinded. It showed that 26% of metformin's diabetes-prevention effect was a drug effect that vanished within two weeks of stopping; the rest held2. In people with diabetes, the rise was real and was usually covered by another drug. In the veterans study, 24% then had low blood sugar on the replacement drugs, and weight rose 3.8 kg on average4.

Do you gain weight after stopping metformin?

Some people do, but there is not much to regain. In the Diabetes Prevention Program, metformin's weight loss averaged about 2% and lasted 10 years, and the size of the loss tracked how faithfully people kept taking it3. In a randomized trial of 55 adults without diabetes on the antipsychotic clozapine, 1,500 mg a day for 24 weeks lowered weight, and after the trial ended, the metformin group's average weight returned to where it started8.

In 44 women with polycystic ovary syndrome (PCOS) followed for 6 months after stopping, those who had taken metformin for about a year went from a median 92 kg to 96 kg. Those who had taken it for about five years held near 87 kg, though their periods came a little less often9. How metformin compares with berberine and a GLP-1 for weight is in our berberine vs metformin vs a GLP-1 guide.

PepVault's weight log charts your weigh-ins over months, so a slow drift after the last tablet shows up as a trend, not a bad morning. Track your weight in PepVault

Do the side effects stop when you stop metformin?

Yes, and they are often the reason people stop. Diarrhea, nausea and gas are metformin's most common effects1, and the Diabetes Prevention Program saw them fade over time even in people who stayed on it3. Vitamin B12 is the slower one: in 29-week trials, about 7% of people with normal B12 dropped below normal, and the label says this "appears to be rapidly reversible with discontinuation" or with B12 supplements1. While you take it, the label asks for B12 to be measured every 2 to 3 years1.

Commonly reported: loose stools and the metallic taste fade within days of the last dose; some people notice more hunger or sugar cravings in the weeks after.

When does the label say to pause or stop metformin?

The label names specific moments. Each one is about the kidneys clearing the drug, because a build-up raises the risk of lactic acidosis, a rare but serious rise of acid in the blood1. eGFR is the blood test that estimates how well the kidneys filter, in mL/min/1.73 m².

SituationWhat the label says1
A scan with iodinated contrast dyeStop at the time of, or before, the scan if eGFR is 30 to 60, with liver disease, alcoholism or heart failure, or when the dye goes into an artery. Recheck eGFR 48 hours later; restart if kidney function is stable
Surgery or a procedure without food and fluidsStop temporarily while food and fluid intake are restricted
eGFR falls below 45The prescriber weighs the benefit and risk of continuing
eGFR below 30Do not use; stop if already taking it
Shock, heart attack, sepsis or another state of low blood oxygen, such as acute heart failureStop when such an event occurs
Suspected lactic acidosisStop at once; treat in hospital

The surgery rule gives no hours; the label's Patient Information says to ask your healthcare provider when to stop and when to start again1. Our guide on GLP-1s before surgery covers the drug class many people take beside it. The kidney line has been questioned by two large records studies. Among 4,278 Scots whose eGFR fell below 30, those who stopped had lower 3-year survival, 63.7% against 70.5%6. In Hong Kong, stopping went with more heart events and kidney failure, and no fewer cases of lactic acidosis5. Records studies cannot rule out that sicker people were the ones taken off it, and neither changes the label: below an eGFR of 30, it says metformin is not used. That call stays with your prescriber.

When to get help While you take metformin, the label says to stop it and call your healthcare provider right away if you feel very weak and tired, or get unusual muscle pain, trouble breathing, unusual sleepiness, or unexplained stomach problems with nausea and vomiting1.

If you take metformin for longevity, what do you lose by stopping?

Less than its reputation suggests. The idea that people on metformin outlive people without diabetes did not hold in Danish national records: metformin-treated diabetes carried a higher death rate than no diabetes, 1.32 times after adjustment and 1.64 times in twin pairs10. And in healthy adults over 65, metformin trimmed what exercise built. In MASTERS, 94 people took 1,700 mg a day or placebo through 14 weeks of strength training, and the placebo group gained more lean mass11. In a 12-week aerobic trial of 53 older adults, it blunted the gains in fitness and insulin sensitivity12.

One finding points the other way. In Kaiser Permanente records, 12,220 people with diabetes who stopped metformin while their kidneys were normal had 1.21 times the rate of dementia diagnoses of 29,126 matched people who stayed on it13. It is a records study of people with diabetes, not a trial, and it says nothing about healthy people taking metformin off-label.

How do you stop metformin with your prescriber?

Stopping a prescribed medicine is your prescriber's decision, made with your numbers in front of them. These steps make that conversation quick.

  1. Tell your prescriber why you want to stop: the stomach effects, a new drug, a lower HbA1c or a planned scan.
  2. Ask for an HbA1c and a fasting glucose before the last tablet, so there is a baseline to compare.
  3. Ask whether anything replaces metformin; most veterans who stopped needed other drugs to get back to their old HbA1c4.
  4. If a new drug is added, ask what low blood sugar feels like on it and what to do.
  5. Ask when to repeat the HbA1c; the test reflects about the last 3 months, so the next one shows the change.
  6. Until the last dose, tell anyone doing a scan with dye or a surgery that you take metformin1.

PepVault's bloodwork log keeps HbA1c, fasting glucose, eGFR and vitamin B12 side by side, so the 3-month panel sits next to the one taken before you stopped. Log it in PepVault

Track it in the app

Sources

  1. Metformin hydrochloride tablets, prescribing information and Patient Information, sections 2.3, 2.4, 5.1, 5.2, 6.1, 12.3 and 14.1. PD-Rx Pharmaceuticals. DailyMed SPL version 20, published Nov 12, 2026. dailymed.nlm.nih.gov
  2. Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care. 2003. PubMed 12663559
  3. Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012. PubMed 22442396
  4. Bradley JN et al. Provider decisions and patient outcomes after premature metformin discontinuation. Diabetes Spectr. 2017. PubMed 28270711
  5. Yang A et al. Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong. EClinicalMedicine. 2024. PubMed 38586590
  6. Lambourg EJ et al. Stopping versus continuing metformin in patients with advanced CKD: a nationwide Scottish target trial emulation study. Am J Kidney Dis. 2025. PubMed 39521399
  7. Leyco T et al. Glycaemic control after metformin discontinuation in diabetic patients with a declining renal function. J Diabetes Res. 2017. PubMed 29230420
  8. Chen CH et al. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight. J Clin Psychiatry. 2013. PubMed 23759461
  9. Kravos NA et al. Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study. Diabetol Metab Syndr. 2021. PubMed 33845893
  10. Keys MT et al. Reassessing the evidence of a survival advantage in type 2 diabetes treated with metformin compared with controls without diabetes. Int J Epidemiol. 2022. PubMed 36287641
  11. Walton RG et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults (MASTERS). Aging Cell. 2019. PubMed 31557380
  12. Konopka AR et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019. PubMed 30548390
  13. Zimmerman SC et al. Metformin cessation and dementia incidence. JAMA Netw Open. 2023. PubMed 37878309

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo